FDA inspection
Teva Pharmaceuticals USA Inc: FDA inspection ending Jan 20, 2004
FDA inspection 311308 · Voluntary Action Indicated (VAI) · Parsippany, NJ
Key facts
| Inspection ID | 311308 |
|---|---|
| Firm | Teva Pharmaceuticals USA Inc |
| FEI number | 3003092769 |
| Address | 400 Interpace Pkwy Bldg A |
| City | Parsippany |
| State | NJ |
| ZIP | 07054-1120 |
| Fiscal year | 2004 |
| Inspection end date | Jan 20, 2004 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data